Dosed first patient in global Phase 3 HAELO study evaluating NTLA-2002 for hereditary angioedema (HAE)Expect to complete enrollment of the HAELO ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

Clustered Regularly Interspaced Short Palindromic Repeats, known as CRISPR, have become a groundbreaking tool in the field of ...

An SCD patient in Bahrain received the gene-editing therapy Casgevy, marking the first time the treatment has been given outside the U.S.

Qilu University of Technology (Shandong Academy of Sciences), Shandong Analysis and Test Center, Jinan 250014, China School of Pharmaceutical Sciences, Qilu University of Technology (Shandong Academy ...

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...

Vertex has entered a reimbursement agreement with NHS England enabling eligible SCD patients to access Casgevy in the public health system.

The Department of Technology is on track to connecting 20,000+ units in San Francisco to free, high speed internet.Learn more ...

Collins, along with Matthew Lau ’25, developed the affordable CRISPRKit to make CRISPR gene-editing technology accessible to high school students underrepresented in the sciences. The kit was ...

Editor's Note: ZDNET's "Technology that Changed Us" series was first published in 2018. We've updated this installment to improve its accuracy and ensure that it reflects recent technology ...

Chief Uche Geoffrey Nnaji, the Nigerian Minister of Innovation, Science, and Technology, in collaboration with Dr. Mustapha Abdullahi, Director General/CEO of the Energy Commission of Nigeria (ECN ...